Florian Stieler

Dr. Florian Stieler


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
FSFlorian Stieler
Florian Stieler
DWDirk Wolff
Dirk Wolff
HSHeike Schmid
Heike Schmid
GWGrit Welzel
Grit Welzel
FWFrederik Wenz
Frederik Wenz
FLFrank Lohr
Frank Lohr

27 September 2013 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
FSFlorian Stieler
Florian Stieler
FWF. Wenz
F. Wenz
MSM. Shi
M. Shi
FLF. Lohr
F. Lohr

1 December 2013 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
FSFlorian Stieler
Florian Stieler
JFJens Fleckenstein
Jens Fleckenstein
ASAnna Simeonova
Anna Simeonova
FWFrederik Wenz
Frederik Wenz
FLFrank Lohr
Frank Lohr

25 October 2009 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
FSFlorian Stieler
Florian Stieler
DWDirk Wolff
Dirk Wolff
FLFrank Lohr
Frank Lohr
VSVolker Steil
Volker Steil
YAYasser Abo-Madyan
Yasser Abo-Madyan
SMSabine Mai
Sabine Mai
Radiotherapy (RT) volumes for anal cancer are large and of moderate complexity when organs at risk (OAR) such as testis, small bowel and bladder are at least partially to be shielded. Volumetric intensity modulated arc therapy (VMAT) might provide OAR-shielding comparable to step-and-shoot intensity modulated radiotherapy (IMRT) for this tumor entity with better treatment efficiency.Based on treatment planning CTs of 8 patients, we compared dose distributions, comformality index (CI), homogeneity index (HI), number of monitor units (MU) and treatment time (TTT) for plans generated for VMAT, 3D-CRT and step-and-shoot-IMRT (optimized based on Pencil Beam (PB) or Monte Carlo (MC) dose calculation) for typical anal cancer planning target volumes (PTV) including inguinal lymph nodes as usually treated during the first phase (0-36 Gy) of a shrinking field regimen.With values of 1.33 +/- 0.21/1.26 +/- 0.05/1.3 +/- 0.02 and 1.39 +/- 0.09, the CI's for IMRT (PB-Corvus/PB-Hyperion/MC-Hyperion) and VMAT are better than for 3D-CRT with 2.00 +/- 0.16. The HI's for the prescribed dose (HI36) for 3D-CRT were 1.06 +/- 0.01 and 1.11 +/- 0.02 for VMAT, respectively and 1.15 +/- 0.02/1.10 +/- 0.02/1.11 +/- 0.08 for IMRT (PB-Corvus/PB-Hyperion/MC-Hyperion). Mean TTT and MU's for 3D-CRT is 220s/225 +/- 11MU and for IMRT (PB-Corvus/PB-Hyperion/MC-Hyperion) is 575s/1260 +/- 172MU, 570s/477 +/- 84MU and 610s748 +/- 193MU while TTT and MU for two-arc-VMAT is 290s/268 +/- 19MU.VMAT provides treatment plans with high conformity and homogeneity equivalent to step-and-shoot-IMRT for this mono-concave treatment volume. Short treatment delivery time and low primary MU are the most important advantages.

31 January 2017 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
DBDaniel Buergy
Daniel Buergy
ASAbdul Wahab M. Sharfo
Abdul Wahab M. Sharfo
BHBen J. M. Heijmen
Ben J. M. Heijmen
PVPeter W. J. Voet
Peter W. J. Voet
SBSebastiaan Breedveld
Sebastiaan Breedveld
FSFlorian Stieler
Florian Stieler
Planning for Volumetric Modulated Arc Therapy (VMAT) may be time consuming and its use is limited by available staff resources. Automated multicriterial treatment planning can eliminate this bottleneck. We compared automatically created (auto) VMAT plans generated by Erasmus-iCycle to manually created VMAT plans for treatment of spinal metastases. Forty-two targets in 32 patients were analyzed. Lungs and kidneys were defined as organs at risk (OARs). Twenty-two patients received radiotherapy on kidney levels, 17 on lung levels, and 3 on both levels. All Erasmus-iCycle plans were clinically acceptable. When compared to manual plans, planning target volume (PTV) coverage of auto plans was significantly better. The Homogeneity Index did not differ significantly between the groups. Mean dose to OARs was lower in auto plans concerning both kidneys and the left lung. One hotspot (>110% of D50%) occurred in the spinal cord of one auto plan (33.2 Gy, D50%: 30 Gy). Treatment time was 7% longer in auto plans. Erasmus-iCycle plans showed better target coverage and sparing of OARs at the expense of minimally longer treatment times (for which no constraint was set).

5 July 2016 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
FSFlorian Stieler
Florian Stieler
FWF. Wenz
F. Wenz
YAY. Abo-Madyan
Y. Abo-Madyan
BSB. Schweizer
B. Schweizer
MPM. Polednik
M. Polednik
SMS. Mai
S. Mai